News | June 11, 2014

Dutch Cancer Patients to Benefit From Erasmus Medical Center's New Linacs

Largest medical center in the Netherlands upgrades with several Elekta Versa HD linear accelerators

June 11, 2014 — Erasmus University Medical Center (Erasmus MC) in Rotterdam, the Netherlands, announced the purchase of Elekta Versa HD linear accelerators (linacs) and a software upgrade including the Mosaiq oncology information system (OIS) and Monaco 5 treatment planning system.

The advanced Versa HD linac system is designed to improve patient care and treat a broad spectrum of cancers. Its high precision and unique beam shaping technology increases tumor targeting, with the aim of delivering better outcomes for cancer patients.

According to Comprehensive Cancer Centre the Netherlands (IKNL), approximately 100,000 people are diagnosed with cancer in the Netherlands annually. Many of them are treated at Erasmus MC, while linacs at Albert Schweitzer hospital, a satellite in Dordrecht, will also be upgraded.

Luca Incrocci, associate professor of radiation oncology at Erasmus MC, said, "Our history of research and collaboration with Elekta means we know we are receiving commitment and quality. Elekta's equipment and solutions will help us to fulfill our vision of being a recognized leader in treating patients with cancer and to meet our goal to develop research programs to improve treatment results and the quality of life of our patients. "

"Erasmus and Elekta have had a collaborative relationship that goes back 10 years," said Thijs van Bommel, business unit manager for the Netherlands at Elekta AB. "They share our pioneering spirit and focus on patient care, education and scientific research. This mindset helped them easily understand the benefits of Elekta solutions including Versa HD, a flexible and integrated treatment system."

For more information: www.elekta.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init